Volcano Presentation at Canaccord Adams Conference to be Webcast

    SAN DIEGO, Aug. 7 /EMWNews/ -- Volcano Corporation

(Nasdaq: VOLC), a provider of intravascular ultrasound (IVUS), functional

measurement (FM) and Optical Coherence Tomography (OCT) products designed

to enhance the diagnosis and treatment of coronary and peripheral vascular

disease, said today that it will be participating in the Canaccord Adams

Annual Global Growth Conference on Tuesday, August 12.



    The presentation by Scott Huennekens, president and chief executive

officer, will begin at 8 a.m., Eastern Daylight Time (5 a.m., Pacific

Daylight Time).



    The presentation will be available through the conference website at

http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=VOLC&item_id=18876

32, or via the company's website at http://www.volcanocorp.com.



    Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devices

designed to facilitate endovascular procedures, enhance the diagnosis of

vascular and structural heart disease and guide optimal therapies. The

company's intravascular ultrasound (IVUS) product line includes ultrasound

consoles that can be integrated directly into virtually any modern cath

lab. Volcano IVUS offers unique features, including both single-use phased

array and rotational IVUS imaging catheters, and advanced functionality

options, such as VH(TM) tissue characterization and ChromaFlo(R). Volcano

also provides functional measurement (FM) consoles and single-use pressure

and flow guide wires and is developing a line of ultra-high resolution

Optical Coherence Tomography (OCT) systems and catheters. Currently, more

than 3,500 Volcano IVUS and FM systems are installed worldwide, with

approximately half of its revenues coming from outside the United States.

For more information, visit the company's website at

http://www.volcanocorp.com